USPSTF Issues Final Recommendation on Screening for Prostate Cancer

On May 8, 2018, the U.S. Preventive Services Task Force (USPSTF) released a final recommendation statement and evidence summaries on screening for prostate cancer. The USPSTF final recommendation provides clinicians and patients with important new information about the benefits and harms of prostate-specific antigen (PSA)-based screening.

For men 55 - 69 years of age, the USPSTF final recommendation calls for informed individual decision-making based on the individual's values and specific clinical circumstances. This is a C recommendation.

The USPSTF recommends against PSA-based screening for prostate cancer in men age 70 and older.

Read the USPSTF Recommendation Statement and access the evidence summary and FAQs.

Posted May 8, 2018